PRAC conclusion of signal of sinus bradycardia with remdesivir (Veklury)

The PRAC has concluded that a causal relationship between the use of remdesivir and sinus bradycardia is at least a reasonable possibility and therefore is to be included as an adverse reaction of unknown frequency in the product literature.

Source:

European Medicines Agency